The Hair Loss Encyclopedia

Search

for
Search:

Learn

0 / 0 results

— no results

Research

5 / 181 results

In Vivo Quantification of the Effects of Radiation and Presence of Hair Follicle Pores on the Proliferation of Fibroblasts in an Acellular Human Dermis in a Dorsal Skinfold Chamber: Relevance for Tissue Reconstruction Following Neoadjuvant Therapy

research In Vivo Quantification of the Effects of Radiation and Presence of Hair Follicle Pores on the Proliferation of Fibroblasts in an Acellular Human Dermis in a Dorsal Skinfold Chamber: Relevance for Tissue Reconstruction Following Neoadjuvant Therapy

2 citations, May 2015 in “PloS one”

Hair follicle pores help cell survival and growth, even after radiation.

research Neoadjuvant Therapy With Disitamab Vedotin in Treating Muscle-Invasive Bladder Cancer: A Case Report

1 citations, April 2023 in “Heliyon”

Disitamab vedotin and gemcitabine effectively treated bladder cancer without major side effects.

research Neoadjuvant Therapy with Disitamab Vedotin in Treating Muscle-Invasive Bladder Cancer: A Case Report

January 2022 in “SSRN Electronic Journal”

Gemcitabine and Disitamab Vedotin effectively and safely reduced bladder cancer in a patient.

research Efficacy of Albumin-Bound Paclitaxel Combined with Nedaplatin in Neoadjuvant Therapy for Esophageal Squamous Cell Carcinoma: A Single-Center Retrospective Observational Study

1 citations, March 2023 in “Medicine”

The combination therapy is effective and well-tolerated for treating esophageal cancer.

A Single-Arm, Open-Label, Phase Ib Clinical Study Evaluating the Efficacy and Safety of Durvalumab in Combination with Albumin-Bound Paclitaxel and Carboplatin as Neoadjuvant Therapy for Resectable Stage III Non-Small Cell Lung Cancer

research A Single-Arm, Open-Label, Phase Ib Clinical Study Evaluating the Efficacy and Safety of Durvalumab in Combination with Albumin-Bound Paclitaxel and Carboplatin as Neoadjuvant Therapy for Resectable Stage III Non-Small Cell Lung Cancer

January 2025 in “Recent Patents on Anti-Cancer Drug Discovery”

The treatment showed high response rates and was well-tolerated, potentially extending patient survival.

View more "neoadjuvant therapy" in research →

Community Join

0 / 0 results

— no results